Wellington Management Group
AVXL icon

Wellington Management Group’s Anavex Life Sciences AVXL Stock Holding History

Wellington Management Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$673K Sell
219,090
-53,141
-20% -$230K ﹤0.01% 1740
2025
Q4 		$969K Sell
272,231
-16,582
-6% -$102K ﹤0.01% 1722
2025
Q3 		$2.57M Buy
288,813
+93,892
+48% +$952K ﹤0.01% 1573
2025
Q2 		$1.8M Buy
194,921
+7,921
+4% +$67.6K ﹤0.01% 1603
2025
Q1 		$1.6M Buy
187,000
+28,326
+18% +$267K ﹤0.01% 1604
2024
Q4 		$1.7M Buy
+158,674
New +$1.22M ﹤0.01% 1609

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Wellington Management Group's AVXL Position: Q1 2026 in Review

Wellington Management Group reduced its Anavex Life Sciences (AVXL) stake by 20% in Q1 2026, selling an estimated $230K and leaving 219,090 shares worth $673K. The position accounts for ﹤0.01% of the portfolio, ranked #1740.

Wellington Management Group first reported a position in AVXL in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.57M in Q3 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Wellington Management Group held 219,090 shares of Anavex Life Sciences worth $673K as of Q1 2026.
  • Wellington Management Group sold 53,141 Anavex Life Sciences shares in Q1 2026, an estimated $230K.
  • Anavex Life Sciences made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1740 holding.
  • Wellington Management Group first reported a position in Anavex Life Sciences in Q4 2024 and has held it in 6 quarters since.
  • Wellington Management Group's Anavex Life Sciences position peaked at $2.57M in Q3 2025.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.